​

Funding Round

Series A - Areteia Therapeutics

Series A - Areteia Therapeutics

Investment Firm

Overview

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.

Announced Date

Jul 12, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Bain Capital Life Sciences

Bain Capital Life Sciences

Bain Capital Life Sciences is a early_stage_venture and private_equity and venture firm.

Participant Investors

8

Investor Name
Participant InvestorPopulation Health Partners
Participant InvestorAccess Biotechnology
Participant InvestorSaturn Partners
Participant InvestorGoogle Ventures
Participant InvestorARCH Venture Partners

Round Details and Background

Areteia Therapeutics raised $350000000 on 2022-07-12 in Series A

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 12, 2022
Series A - Areteia Therapeutics
8-350.0M
Feb 13, 2024
Series A - Areteia Therapeutics
10-75.0M

Recent Activity

There is no recent news or activity for this profile.